Xi Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xi Luo has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Anwei Chen
College of Environment and Ecology, Hunan Agricultural University, Changsha 410128, PR China
1 shared publication - Chaohong Liu
Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
1 shared publication - Cheng Wang
Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China
1 shared publication Cong-Yi Wang
Huazhong University of Science and Technology
1 shared publication- Dan Huang
Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
1 shared publication Dandan Huang
Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China
1 shared publication
Latest Publications
- 1 December 2023
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 325 (6) , E744-E754
Kruppel-like factor 14 ameliorated obesity and related metabolic disorders by promoting adipose tissue browning
Our study first explored the role of KLF14 in the development and progression of HFD-induced obesity in male mice. Its beneficial effect on adipose browning and metabolic disorders suggests that KLF14 may provide us a new therapeutic strategy for obesity and related metabolic complications. This health problem is of global concern and needs to be addressed.
- 1 December 2023
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 325 (6) , E744-E754
Kruppel-like factor 14 ameliorated obesity and related metabolic disorders by promoting adipose tissue browning
Our study first explored the role of KLF14 in the development and progression of HFD-induced obesity in male mice. Its beneficial effect on adipose browning and metabolic disorders suggests that KLF14 may provide us a new therapeutic strategy for obesity and related metabolic complications. This health problem is of global concern and needs to be addressed.
- 4 February 2020
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 77 (21) , 4379-4395
CX3CR1 positively regulates BCR signaling coupled with cell metabolism via negatively controlling actin remodeling
As an important chemokine receptor, the role of CX3CR1 has been studied extensively on the migration of lymphocytes including T and B cells. Although CX3CR1+ B cells have immune suppressor properties, little is known about its role on the regulation of BCR signaling and B cell differentiation as well as the underlying molecular mechanism. We have used CX3CR1 KO mice to study the effect of CX3CR1 deficiency on BCR signaling and B cell differentiation. Interestingly, we found that proximal BCR signaling, such as the activation of CD19, BTK and SHIP was reduced in CX3CR1 KO B cells upon antigenic stimulation. However, the activation of mTORC signaling was enhanced. Mechanistically, we found that the reduced BCR signaling in CX3CR1 KO B cells was due to reduced BCR clustering, which is caused by the enhanced actin accumulation by the plasma membrane via increased activation of WASP. This caused an increased differentiation of MZ B cells in CX3CR1 KO mice and an enhanced generation of plasma cells (PC) and antibodies. Our study shows that CX3CR1 regulates BCR signaling via actin remodeling and affects B cell differentiation and the humoral immune response.
- 4 February 2020
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 77 (21) , 4379-4395
CX3CR1 positively regulates BCR signaling coupled with cell metabolism via negatively controlling actin remodeling
As an important chemokine receptor, the role of CX3CR1 has been studied extensively on the migration of lymphocytes including T and B cells. Although CX3CR1+ B cells have immune suppressor properties, little is known about its role on the regulation of BCR signaling and B cell differentiation as well as the underlying molecular mechanism. We have used CX3CR1 KO mice to study the effect of CX3CR1 deficiency on BCR signaling and B cell differentiation. Interestingly, we found that proximal BCR signaling, such as the activation of CD19, BTK and SHIP was reduced in CX3CR1 KO B cells upon antigenic stimulation. However, the activation of mTORC signaling was enhanced. Mechanistically, we found that the reduced BCR signaling in CX3CR1 KO B cells was due to reduced BCR clustering, which is caused by the enhanced actin accumulation by the plasma membrane via increased activation of WASP. This caused an increased differentiation of MZ B cells in CX3CR1 KO mice and an enhanced generation of plasma cells (PC) and antibodies. Our study shows that CX3CR1 regulates BCR signaling via actin remodeling and affects B cell differentiation and the humoral immune response.
- Open Access
- 1 April 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (16) , 11348-11357
Poly(ADP-ribose) Polymerase 1 Is a Key Regulator of Estrogen Receptor α-dependent Gene Transcription
- 1 April 2013
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 288 (16) , 11348-11357
Open AccessPoly(ADP-ribose) Polymerase 1 Is a Key Regulator of Estrogen Receptor α-dependent Gene Transcription